US Stock MarketDetailed Quotes

PCVX Vaxcyte

Watchlist
  • 64.550
  • +0.840+1.32%
Close May 2 16:00 ET
  • 64.550
  • 0.0000.00%
Post 17:08 ET
7.02BMarket Cap-15591P/E (TTM)

About Vaxcyte Company

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Company Profile

SymbolPCVX
Company NameVaxcyte
Listing DateJun 12, 2020
Issue Price16.00
Founded2013
CEOMr. Grant E. Pickering
MarketNASDAQ
Employees254
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address825 Industrial Road,Suite 300
CitySan Carlos
ProvinceCalifornia
CountryUnited States of America
Zip Code94070
Phone1-650-837-0111
Websitehttp://www.vaxcyte.com

Company Executives

  • Name
  • Position
  • Salary
  • Grant E. Pickering
  • Director and Chief Executive Officer
  • 12.14M
  • Mikhail Eydelman
  • Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
  • --
  • Jim Wassil
  • Executive Vice President and Chief Operating Officer
  • 5.40M
  • Andrew L. Guggenhime
  • Chief Financial Officer and President
  • 5.42M
  • Elvia Cowan
  • Director, Senior Vice President, Finance and Principal Accounting Officer
  • --
  • Dr. Carlos V. Paya,M.D.,PhD
  • Chairman of the Board
  • 724.22K
  • Annie Seibold Drapeau
  • Independent Director
  • 704.22K
  • Teri Loxam
  • Independent Director
  • 704.22K
  • Dr. Heath Lukatch, PhD
  • Independent Director
  • 691.72K
  • Halley E. Gilbert
  • Independent Director
  • 704.22K
  • Jacks Lee
  • Independent Director
  • --
  • Dr. Peter Hirth, PhD
  • Independent Director
  • 696.72K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg